PRINCETON, NJ -- (MARKET WIRE) -- May 16, 2007 -- Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company that develops and markets dermatology products, today announced the appointment of Braham Shroot, Ph.D. to the newly created position of Chief Scientific Officer effective May 16, 2007. In this role, he will manage the company’s research and development activities reporting to Geert Cauwenbergh, Ph.D., Chief Executive Officer of Barrier Therapeutics.
